Key regions: China, South Korea, Japan, Canada, India
The Wound Care (Pharmacies) market in Turkey is experiencing steady growth due to increasing customer preferences for advanced wound care products, along with several local special circumstances and underlying macroeconomic factors.
Customer preferences: Customers in the Wound Care (Pharmacies) market in Turkey are increasingly demanding advanced wound care products that offer better healing and faster recovery. This preference is driven by the growing awareness about the benefits of advanced wound care, such as reduced healing time, lower risk of infection, and improved patient comfort. Additionally, customers are seeking products that are easy to use and provide long-lasting results. As a result, there is a rising demand for innovative wound care products in the Turkish market.
Trends in the market: One of the key trends in the Wound Care (Pharmacies) market in Turkey is the increasing adoption of advanced wound dressings. These dressings are designed to provide optimal wound healing conditions by maintaining a moist environment, promoting tissue regeneration, and preventing infection. As customers become more aware of the benefits of advanced dressings, there is a shift from traditional wound care products to these innovative solutions. Another trend in the market is the growing popularity of wound care products with antimicrobial properties. With the increasing incidence of antibiotic-resistant infections, customers are looking for wound care products that can effectively prevent and treat infections. Antimicrobial dressings and ointments are being preferred by customers as they provide an added layer of protection against bacteria and other microorganisms.
Local special circumstances: Turkey has a large aging population, which is driving the demand for wound care products. As individuals age, their skin becomes more susceptible to wounds and injuries, making wound care an essential part of their healthcare routine. This demographic factor is contributing to the growth of the Wound Care (Pharmacies) market in Turkey. Furthermore, Turkey has a high prevalence of chronic diseases such as diabetes and cardiovascular diseases, which are associated with an increased risk of chronic wounds. This creates a significant need for wound care products that can effectively manage and heal chronic wounds. As a result, the demand for wound care products in Turkey is further boosted.
Underlying macroeconomic factors: The growing healthcare expenditure in Turkey is playing a significant role in the development of the Wound Care (Pharmacies) market. The government has been increasing its healthcare budget to improve access to healthcare services and promote the adoption of advanced medical technologies. This has resulted in better availability of wound care products in pharmacies across the country. Additionally, the increasing disposable income of the population in Turkey is enabling more people to afford advanced wound care products. As individuals have more purchasing power, they are willing to invest in high-quality wound care products that offer better outcomes. This is driving the growth of the Wound Care (Pharmacies) market in Turkey. In conclusion, the Wound Care (Pharmacies) market in Turkey is witnessing growth due to increasing customer preferences for advanced wound care products, such as advanced dressings and antimicrobial products. The local special circumstances, including the aging population and high prevalence of chronic diseases, further contribute to the market growth. Moreover, the underlying macroeconomic factors, such as the growing healthcare expenditure and increasing disposable income, are creating a favorable environment for the development of the market.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
